| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |